Study Shows Relationship Between Blood Test Values and Alzheimer’s Disease Progression
PeopleBio (CEO Kang Seong-min) targets patients with different stages of Alzheimer’s disease, including normal people, patients with mild cognitive impairment (MCI) and patients with Alzheimer’s dementia, and measures changes in blood test values “AlzOn”, the accumulation of amyloid in the brain, neuropsychological tests and cerebral cortex.On the 22nd, the publication of an article on the […]
Gantenerumab: Disappointing Results from Phase 3 Clinical Trial for Alzheimer’s Disease
Gantenerumab’s Potential for Alzheimer’s Disease Disappoints in Final Clinical Evaluation Global pharmaceutical company Roche has unveiled the results of the final clinical evaluation of its new drug, gantenerumab, designed to treat Alzheimer’s disease. The findings, published in the prestigious New England Journal of Medicine, paint a disappointing picture of the drug’s efficacy in improving the […]
New Pathological Network Uncovered by KAIST Research Team Offers Clue to Alzheimer’s Disease Treatment
Groundbreaking Research by KAIST Unveils New Pathological Network in Alzheimer’s Disease The number of people suffering from Alzheimer’s disease has seen a rapid increase in recent years, but the identification of the cause and the development of treatments have been slow. However, a domestic research team has presented a breakthrough in the search for a […]
Researchers Discover Cause of Nerve Cell Damage in Early Dementia Patients
Breakthrough Research Identifies Cause of Nerve Cell Damage in Early Dementia Patients A groundbreaking study conducted by the Korea Brain Research Institute has successfully pinpointed the underlying cause of nerve cell damage in individuals suffering from early stages of dementia. The research team, led by Senior Researcher Youngsik Choi from the Brain Disease Development Research […]
